Stock screenerAll disclosures →
EDGAR →
CADL
Conviction 100HealthcareScan · Thu, Jun 25, 2026Three white soldiers
CADL$9.48+2.21%
ResistanceSupportVol 14Vol MA14 2.35M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price9.48
Change+2.21%
Gap-0.16%
Rel volume2.29×
Avg volume2.2M
Avg $ vol19.05M
SMA 208.60
SMA 507.87
SMA 2005.98
Price vs 50+20.43%
Price vs 200+58.55%
MA stackbullish
50/200 cross—
Supertrendup · 7.58
RSI (14)65
MACD hist0.05
MACD crossbull · 1d
Stoch %K / %D92 / 81
ADX (14)35
+DI / −DI28 / 10
RSI divergence—
MACD divergence—
ATR %+6.16%
ADR %6.71%
52w high9.48
52w low4.42
From 52w high+0.00%
Above 52w low+114.37%
New 52w highYes
SqueezeFired
Bollinger width20.18%
%B1.01
Donchian pos91.96%
Donchian high9.61
Donchian low7.93
AVWAP (52w high)9.39
vs AVWAP high+0.96%
AVWAP (52w low)6.73
vs AVWAP low+40.72%
OBV trendUp
Chaikin MF (20)0.03
Today vs 20d2.29×
Avg vol (14d)2.35M
Avg vol (20d)2.2M
Avg $ vol (20d)19.05M
Market cap694.24M
RS 3m (vs SPY)+80.47%
RS 6m (vs SPY)+58.69%
RS line new highYes
Trend template8/8
Technical rank93.0
1 week+18.59%
1 month+19.18%
3 months+89.88%
6 months+59.51%
1 year+95.36%
YTD+74.17%
P/E-18.18
P/B5.03
P/S—
P/FCF-17.85
EPS-0.7200
Div yield—
ROE-27.66%
ROA-18.91%
Debt/Eq0.01
Current28.05
EV/EBITDA-10.55
Gross margin—
Net margin—
Rev growth0.00%
EPS growth30.80%
Price target20.60
Target upside117.41%
Analyst ratingBuy
Institutional62.41%
Ent. value501.13M
Revenue31K
Net income-8.86M
Gross profit—
Free cash flow-38.9M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out73.27M
Employees55
ListedTue, Jul 27, 2021
Free float42.26M
Float %77.0%
Short interest14.16M
Days to cover7.6d
Short volume47.8%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.14 vs −$0.22
Last surprise+36.4% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank93.0 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree white soldiers
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CADL
No recent disclosed trades by Congress in CADL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CADL · 9 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Benz Edward J. JR Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Loggia Nicoletta Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Martell Christopher Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Nabel Gary J. Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
PAPA JOSEPH C Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Manning Paul B Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Gaeta Renee Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Nguyen Diem Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Radhakrishnan Maha Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
SEC filings
EDGAR filings in CADL · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.